Cellsource Co., Ltd. (4880) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cellsource Co., Ltd. (4880:JPX), powered by AI.

Current Price
¥394
Sector
Healthcare
What is the Cellsource Co., Ltd. stock price forecast?

Cellsource Co., Ltd. is currently trading at ¥394. View real-time AI analysis on Alpha Lenz.

What is Cellsource Co., Ltd. insider trading activity?

View the latest insider trading data for Cellsource Co., Ltd. on Alpha Lenz.

What is Cellsource Co., Ltd.'s P/E ratio?

View Cellsource Co., Ltd.'s valuation metrics on Alpha Lenz.

Cellsource Co., Ltd.

JPX · 4880
¥394
Ask about Cellsource Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Cellsource Co., Ltd.'s ROE is 0.2%. Explore profitability and growth together.

Ask for details

Company Overview

Cellsource Co., Ltd. is a biotechnology company that focuses on the development and commercialization of regenerative medicine products. Specializing in cell-based therapies, Cellsource aims to leverage cutting-edge technology and scientific expertise to contribute to advancements in medical treatments for various ailments and conditions. The company's primary objective is to harness the potential of cell therapy to improve patient outcomes and quality of life. Operating within the dynamic and fast-evolving biotechnology sector, Cellsource conducts research and development activities to pioneer innovative medical solutions. The firm plays an integral role in the biotech industry, collaborating with research institutions, healthcare providers, and other stakeholders to bring innovative therapies to market. As a key player in the regenerative medicine landscape, Cellsource is committed to advancing the frontiers of medical technology and contributing to the future of personalized medicine through its research and product offerings.

CEOMr. Takashi Sawada
SectorHealthcare
IndustryBiotechnology
Employees151

Company Statistics

FY 2025

Profile

N/AMarket Cap
¥3,711,455,000Revenue
0.00Shares Out
151Employees

Margins

56.24%Gross
8.71%EBITDA
4.49%Operating
2.96%Pre-Tax
0.29%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-4.59%Rev 3Yr
14.87%Rev 5Yr
-52.66%Op Inc 3Yr
-16.70%Op Inc 5Yr
-78.12%Net Inc 3Yr
-47.76%Net Inc 5Yr

Returns

0.15%ROA
0.18%ROE
1.58%ROIC

Financial Health

¥4,711,820,000Cash & Cash Equivalents
¥-3,704,675,000Net Debt
16.74%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cellsource Co., Ltd. (ticker: 4880) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 151 employees.

The current price is 394 with a P/E ratio of -x and P/B of -x.

ROE is 0.18% and operating margin is 4.49%. Annual revenue is $3.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cellsource Co., Ltd. (Healthcare) Stock Forecast & Analysis ¥394 | Alpha Lenz